Regulatory review support multiple-award blanket purchase agreement (BPA)
Active Awarded
- Contract number
- 75F40125A00022
- Awardee
-
A P Ventures, LLC UEI CF46HNY9JH31
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Task orders
- 1 $1,272,178 obligated
Award facts
- Opportunity
-
- 75F40124Q00448 Solicitation number
- Combined order value
-
- $1,272,178 Current, with exercised options
- $5,237,175 Potential, with all options
- Last date to order 26% complete
- IDV ceiling 1% used
- $99,999,935.00
- Maximum order
- $99,999,935.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 541511 Custom Computer Programming Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 8 offers Multiple Award, Fair Opportunity
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
This Blanket Purchase Agreement (BPA) was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to the prime contractor A P Ventures, LLC, a woman-owned small disadvantaged business based in Columbia, Maryland. The contract has a ceiling value of $99,999,935.00 and a period of performance through February 2, 2030.
The BPA is intended to provide the FDA with a wide range of regulatory review support services. A P Ventures, as the prime contractor, is an experienced government services provider with expertise in areas such as IT modernization, software development, human resources, training, project management, and technical consulting. The company holds several significant Indefinite Delivery Vehicle (IDV) contracts, including the $50 billion 8(a) STARS III GWAC, the $2.3 billion HCaTS 8(a) contract, and multiple OASIS+ vehicles, which allow it to deliver customized professional services across various functional domains. The task orders issued under this BPA are expected to cover a diverse array of regulatory review support activities for the FDA.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| AI-assisted review of clinical trial protocols | Food and Drug Administration | $1,272,178 |
Quick answers
Who was awarded contract 75F40125A00022?
75F40125A00022 was awarded to A P Ventures, LLC by Food and Drug Administration (Department of Health and Human Services) on September 10, 2025.
How much is contract 75F40125A00022 worth?
Orders under 75F40125A00022 have obligated $1,272,178. Their combined potential value, with all options, is $5,237,175. 75F40125A00022's own ceiling is $99,999,935. A single order can be worth up to $99,999,935.
How many orders have been placed under contract 75F40125A00022?
1 order has been placed under 75F40125A00022, the latest on September 30, 2026.
Who can order from contract 75F40125A00022?
75F40125A00022 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 75F40125A00022 under another contract?
Yes. 75F40125A00022 is a blanket purchase agreement under GS35F281CA, a federal supply schedule, on Regulatory Review Support.
Was contract 75F40125A00022 competed?
The extent of competition for 75F40125A00022 was full and open competition. The government received 8 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV